PATENT CLAIM ANALYSIS

Application Number: 16172573
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["424", "465000"]

Abstract:
Provided are solid dispersions of Compound I having the formula: wherein Compound I is substantially amorphous, methods of manufacturing said solid dispersions, and methods of using said solid dispersions.

Claim (Index 39):
The method according to  claim 38 , wherein the BRAF mutation related disease or condition is hepatocellular carcinoma, Langerhan's cell histiocytosis, Erdheim Chester Disease, gastrointestinal stromal cell tumours, hairy cell leukemia, hairy cell leukemia, melanoma, colorectal cancer, papillary thyroid cancer, anaplastic thyroid cancer, ovarian cancer, non-small-cell lung cancer, colorectal cancer, glioblastoma multiforme, prostate cancer, gastric cancer, cholangiocarcinoma, or Barrett's esophageal cancer.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 97.0
- Lexical Diversity: 1.5
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15128714', '13843224', '12934296', '13183119', '16035771']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7218647300249671
- 35 USC 102 Novelty (BERT): 0.5122655008892929
- Combined Prediction Score: 0.7009048071113997
- Mean Citation Score: 162.41165800000005
- Max Citation Score: 169.05733
- Similarity Product: 91.45991621500971

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test